DrugCite
Search

TERCIAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Tercian Adverse Events Reported to the FDA Over Time

How are Tercian adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Tercian, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Tercian is flagged as the suspect drug causing the adverse event.

Most Common Tercian Adverse Events Reported to the FDA

What are the most common Tercian adverse events reported to the FDA?

Somnolence
72 (1.71%)
Malaise
66 (1.57%)
Cytolytic Hepatitis
61 (1.45%)
Drug Exposure During Pregnancy
52 (1.24%)
Agitation
46 (1.09%)
Renal Failure Acute
45 (1.07%)
Coma
43 (1.02%)
Dyskinesia
43 (1.02%)
Suicide Attempt
43 (1.02%)
Blood Creatine Phosphokinase Increa...
42 (1%)
Intentional Overdose
42 (1%)
Show More Show More
Vomiting
40 (.95%)
Anxiety
39 (.93%)
Fall
38 (.9%)
Pyrexia
38 (.9%)
Confusional State
37 (.88%)
Hyperthermia
35 (.83%)
Neuroleptic Malignant Syndrome
33 (.78%)
Rhabdomyolysis
32 (.76%)
Condition Aggravated
31 (.74%)
Extrapyramidal Disorder
31 (.74%)
Hypotension
29 (.69%)
Cardiac Arrest
27 (.64%)
Drug Withdrawal Syndrome
27 (.64%)
Drug Interaction
26 (.62%)
Insomnia
26 (.62%)
Septic Shock
25 (.59%)
Fatigue
24 (.57%)
Premature Baby
24 (.57%)
Suicidal Ideation
24 (.57%)
Tachycardia
24 (.57%)
Asthenia
23 (.55%)
Cholestasis
23 (.55%)
Dysstasia
23 (.55%)
Pulmonary Embolism
23 (.55%)
Death
22 (.52%)
Dyspnoea
22 (.52%)
Muscular Weakness
22 (.52%)
Neutropenia
22 (.52%)
Overdose
22 (.52%)
Tremor
22 (.52%)
Atrial Septal Defect
21 (.5%)
Convulsion
21 (.5%)
Dehydration
21 (.5%)
Hypersomnia
21 (.5%)
Renal Failure
21 (.5%)
Vertigo
21 (.5%)
Agranulocytosis
20 (.48%)
Amnesia
20 (.48%)
Colitis Ischaemic
19 (.45%)
Cardio-respiratory Arrest
18 (.43%)
Hyperkalaemia
18 (.43%)
Presyncope
18 (.43%)
Crying
17 (.4%)
Hepatitis Cholestatic
17 (.4%)
Loss Of Consciousness
17 (.4%)
Thrombocytopenia
17 (.4%)
Aggression
16 (.38%)
C-reactive Protein Increased
16 (.38%)
Constipation
16 (.38%)
Disorientation
16 (.38%)
Leukopenia
16 (.38%)
Respiratory Distress
16 (.38%)
Bradycardia
15 (.36%)
Congenital Musculoskeletal Anomaly
15 (.36%)
Drug Toxicity
15 (.36%)
Electrocardiogram Qt Prolonged
15 (.36%)
Gamma-glutamyltransferase Increased
15 (.36%)
Hyponatraemia
15 (.36%)
Pneumonia Aspiration
15 (.36%)
Heart Rate Increased
14 (.33%)
Inflammation
14 (.33%)
Respiratory Arrest
14 (.33%)
Abnormal Behaviour
13 (.31%)
Altered State Of Consciousness
13 (.31%)
Arrhythmia
13 (.31%)
Blood Alkaline Phosphatase Increase...
13 (.31%)
Musculoskeletal Chest Pain
13 (.31%)
Sepsis
13 (.31%)
Anaemia
12 (.29%)
Atrial Fibrillation
12 (.29%)
Completed Suicide
12 (.29%)
Diabetes Mellitus
12 (.29%)
Headache
12 (.29%)
Hypertriglyceridaemia
12 (.29%)
Hypothermia
12 (.29%)
Alanine Aminotransferase Increased
11 (.26%)
Caesarean Section
11 (.26%)
Dysarthria
11 (.26%)
Gastrointestinal Obstruction
11 (.26%)
Leukocytosis
11 (.26%)
Lung Disorder
11 (.26%)
Maternal Drugs Affecting Foetus
11 (.26%)
Muscle Rigidity
11 (.26%)
Orthostatic Hypotension
11 (.26%)
Parkinsonism
11 (.26%)
Pruritus
11 (.26%)
Abdominal Pain
10 (.24%)
Diarrhoea
10 (.24%)
Hepatitis
10 (.24%)
Hepatomegaly
10 (.24%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Tercian, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Tercian is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Tercian

What are the most common Tercian adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Tercian, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Tercian is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Tercian According to Those Reporting Adverse Events

Why are people taking Tercian, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
181
Product Used For Unknown Indication
87
Anxiety
75
Psychotic Disorder
66
Depression
62
Schizophrenia
47
Show More Show More
Agitation
39
Bipolar Disorder
25
Ill-defined Disorder
18
Mental Disorder
18
Bipolar I Disorder
17
Abnormal Behaviour
16
Sleep Disorder
13
Insomnia
12
Sedation
10
Major Depression
8
Drug Exposure During Pregnancy
7
Brief Psychotic Disorder With Marke...
7
Hallucination
7
Delusion
6
Anxiolytic Therapy
6
Delirium
5
Personality Disorder
5
Dysthymic Disorder
4
Autism
4
Confusional State
4
Persecutory Delusion
4
Mania
3
Aggression
3
Acute Psychosis
3
Psychiatric Decompensation
3
Suicide Attempt
3
Schizophrenia, Paranoid Type
3
Foetal Exposure During Pregnancy
2
Systemic Lupus Erythematosus
2
Intentional Overdose
2
Neuroleptic Malignant Syndrome
2
Phobia
2
Delusional Disorder, Persecutory Ty...
2
Neurosis
2
Abdominal Pain
2
Paranoia
2
Tuberculosis
1
Potentiating Drug Interaction
1
Dissociative Identity Disorder
1
Restlessness
1
Dementia
1
Anxiety Disorder
1
Depressive Symptom
1
Schizotypal Personality Disorder
1
Adverse Event
1

Tercian Case Reports

What Tercian safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Tercian. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Tercian.